SE8300623L - Farmaceutisk komposition innehallande stabil mikrokristallin cis-platina(ii)-diammindiklorid (cisplatin) - Google Patents
Farmaceutisk komposition innehallande stabil mikrokristallin cis-platina(ii)-diammindiklorid (cisplatin)Info
- Publication number
- SE8300623L SE8300623L SE8300623A SE8300623A SE8300623L SE 8300623 L SE8300623 L SE 8300623L SE 8300623 A SE8300623 A SE 8300623A SE 8300623 A SE8300623 A SE 8300623A SE 8300623 L SE8300623 L SE 8300623L
- Authority
- SE
- Sweden
- Prior art keywords
- cisplatin
- microcristallin
- platina
- cis
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G55/00—Compounds of ruthenium, rhodium, palladium, osmium, iridium, or platinum
- C01G55/002—Compounds containing, besides ruthenium, rhodium, palladium, osmium, iridium, or platinum, two or more other elements, with the exception of oxygen or hydrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/74—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by peak-intensities or a ratio thereof only
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/51—Particles with a specific particle size distribution
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/61—Micrometer sized, i.e. from 1-100 micrometer
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/80—Compositional purity
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/081,301 US4302446A (en) | 1979-10-02 | 1979-10-02 | Pharmaceutical compositions |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8300623L true SE8300623L (sv) | 1983-02-07 |
SE8300623D0 SE8300623D0 (sv) | 1983-02-07 |
SE455469B SE455469B (sv) | 1988-07-18 |
Family
ID=22163311
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8104661A SE450830B (sv) | 1979-10-02 | 1981-08-03 | Stabil mikrokristallin cis-platina(ii)-diamin-diklorid och forfarande for dess framstellning |
SE8300623A SE455469B (sv) | 1979-10-02 | 1983-02-07 | Farmaceutisk komposition innehallande stabil, mikrokristallin cis-platina (ii)-diammindiklorid |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8104661A SE450830B (sv) | 1979-10-02 | 1981-08-03 | Stabil mikrokristallin cis-platina(ii)-diamin-diklorid och forfarande for dess framstellning |
Country Status (12)
Country | Link |
---|---|
US (2) | US4302446A (sv) |
JP (1) | JPS5832029A (sv) |
AT (1) | AT375326B (sv) |
AU (1) | AU551710B2 (sv) |
BE (1) | BE890192A (sv) |
CA (1) | CA1152289A (sv) |
CH (1) | CH647216A5 (sv) |
DE (1) | DE3133443A1 (sv) |
FR (1) | FR2511357B1 (sv) |
GB (1) | GB2103591B (sv) |
NL (1) | NL8103784A (sv) |
SE (2) | SE450830B (sv) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1153974B (it) * | 1982-09-23 | 1987-01-21 | Erba Farmitalia | Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento |
DE3305248C2 (de) * | 1983-02-16 | 1987-04-09 | Degussa Ag, 6000 Frankfurt | Verfahren zur Reinigung von cis-Platin-(II)-diammin-dichlorid |
NL8303657A (nl) * | 1983-10-24 | 1985-05-17 | Pharmachemie Bv | Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan. |
US4699978A (en) * | 1985-01-18 | 1987-10-13 | The Trustees Of Columbia University In The City Of New York | Site-specific chiral ruthenium (II) and cobalt (III) antitumor agents |
US4686104A (en) * | 1985-04-30 | 1987-08-11 | Sloan-Kettering Institute For Cancer Research | Methods of treating bone disorders |
JPS61293655A (ja) * | 1985-05-31 | 1986-12-24 | Trinity Ind Corp | 砂型鋳造品の砂落し装置 |
CS269719B1 (en) * | 1986-12-29 | 1990-05-14 | Kiss Frantisek | Platinum cytostatic |
JP2657393B2 (ja) * | 1988-05-18 | 1997-09-24 | 日本化薬株式会社 | 化学塞栓療法剤 |
FI895340A0 (fi) * | 1988-11-14 | 1989-11-09 | Bristol Myers Squibb Co | Hypertonisk cisplatin-loesning. |
US4946689A (en) * | 1988-11-23 | 1990-08-07 | Bristol-Myers Company | Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin |
US8728536B2 (en) * | 1996-10-16 | 2014-05-20 | Etex Corporation | Chemotherapeutic composition using nanocrystalline calcium phosphate paste |
EP0949203A4 (en) * | 1996-12-25 | 2006-01-18 | Nippon Kayaku Kk | FINE CISPLATIN POWDER AND PROCESS FOR PRODUCING THE SAME |
US6074626A (en) * | 1998-03-20 | 2000-06-13 | Molecular Radiation Management, Inc. | Radioactive cisplatin in the treatment of cancer |
WO2001024763A2 (en) | 1999-10-01 | 2001-04-12 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
AUPQ641100A0 (en) * | 2000-03-23 | 2000-04-15 | Australia Nuclear Science & Technology Organisation | Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents |
ES2248321T3 (es) * | 2000-04-24 | 2006-03-16 | Teva Pharmaceutical Industries Ltd. | Hemitartrato de zolpidem. |
EP1600159A1 (en) | 2000-04-24 | 2005-11-30 | Teva Pharmaceutical Industries Ltd | A method for synthesizing different Zolpidem hemitartrate derivatives |
GB0011903D0 (en) * | 2000-05-18 | 2000-07-05 | Astrazeneca Ab | Combination chemotherapy |
SK1472004A3 (en) * | 2001-09-24 | 2004-10-05 | Tosk Inc | Reduced toxicity cisplatin formulations and methods for using the same |
EP1603810B1 (en) * | 2003-03-15 | 2010-08-11 | Brin Tech International Limited | Medicament package |
US20060063832A1 (en) * | 2003-03-31 | 2006-03-23 | Pliva-Lachema A.S. A Czech Republic Corporation | Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof |
WO2005037821A2 (en) * | 2003-10-16 | 2005-04-28 | Teva Pharmaceutical Industries Ltd. | Preparation of candesartan cilexetil |
ES2300979T3 (es) * | 2004-01-05 | 2008-06-16 | Teva Pharmaceutical Industries Ltd. | Procedimiento para la produccion de sildenafilo base y de su sal citrato. |
WO2005077941A2 (en) * | 2004-02-11 | 2005-08-25 | Teva Pharmaceutical Industries Ltd. | Candesartan cilexetil polymorphs |
US20080085882A1 (en) * | 2006-08-18 | 2008-04-10 | University Of North Texas Health Science Center At Fort Worth | Compositions and Methods for Potentiation of Cancer Agents |
US8173686B2 (en) * | 2006-11-06 | 2012-05-08 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8178564B2 (en) * | 2006-11-06 | 2012-05-15 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8168662B1 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8168661B2 (en) * | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US20110033528A1 (en) * | 2009-08-05 | 2011-02-10 | Poniard Pharmaceuticals, Inc. | Stabilized picoplatin oral dosage form |
CA2677639A1 (en) * | 2007-02-09 | 2008-08-14 | Poniard Pharmaceuticals, Inc. | Encapsulated picoplatin |
TW200916094A (en) * | 2007-06-27 | 2009-04-16 | Poniard Pharmaceuticals Inc | Stabilized picoplatin dosage form |
US20100260832A1 (en) * | 2007-06-27 | 2010-10-14 | Poniard Pharmaceuticals, Inc. | Combination therapy for ovarian cancer |
WO2009011861A1 (en) * | 2007-07-16 | 2009-01-22 | Poniard Pharmaceuticals, Inc. | Oral formulations for picoplatin |
EP2244714A4 (en) * | 2008-02-08 | 2012-06-06 | Poniard Pharmaceuticals Inc | USE OF PICOPLATIN AND BEVACIZUMAB TO TREAT COLORECTAL CANCER |
AU2008352603B2 (en) | 2008-03-14 | 2012-05-31 | Bionumerik Pharmaceuticals, Inc. | Compositions and methods of use of compounds to increase cancer patient survival time |
WO2009113983A1 (en) | 2008-03-14 | 2009-09-17 | Bionumerik Pharmaceuticals, Inc. | Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions |
US20100035853A1 (en) * | 2008-08-07 | 2010-02-11 | Hyogo College Of Medicine | Method for preventing or treating cisplatin-induced nephrotoxicity |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4079121A (en) * | 1974-12-13 | 1978-03-14 | Mobil Oil Corporation | Complexes of beta platinum chloride and ammonia |
CA1119954A (en) * | 1978-05-30 | 1982-03-16 | Edmund S. Granatek | Aqueous solution of cisplatin |
US4273755A (en) * | 1979-08-16 | 1981-06-16 | Mpd Technology Corporation | Preparation of platinum complexes |
-
1979
- 1979-10-02 US US06/081,301 patent/US4302446A/en not_active Expired - Lifetime
-
1980
- 1980-09-29 US US06/191,982 patent/US4322391A/en not_active Expired - Lifetime
-
1981
- 1981-08-03 SE SE8104661A patent/SE450830B/sv not_active IP Right Cessation
- 1981-08-04 GB GB08123759A patent/GB2103591B/en not_active Expired
- 1981-08-07 AU AU73906/81A patent/AU551710B2/en not_active Ceased
- 1981-08-12 NL NL8103784A patent/NL8103784A/nl not_active Application Discontinuation
- 1981-08-12 JP JP56125390A patent/JPS5832029A/ja active Granted
- 1981-08-14 FR FR8115760A patent/FR2511357B1/fr not_active Expired
- 1981-08-21 CA CA000384425A patent/CA1152289A/en not_active Expired
- 1981-08-24 DE DE19813133443 patent/DE3133443A1/de active Granted
- 1981-08-28 AT AT0374981A patent/AT375326B/de not_active IP Right Cessation
- 1981-09-02 BE BE0/205848A patent/BE890192A/fr not_active IP Right Cessation
- 1981-09-10 CH CH5865/81A patent/CH647216A5/de not_active IP Right Cessation
-
1983
- 1983-02-07 SE SE8300623A patent/SE455469B/sv not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB2103591A (en) | 1983-02-23 |
SE8104661L (sv) | 1983-02-04 |
SE455469B (sv) | 1988-07-18 |
AT375326B (de) | 1984-07-25 |
AU7390681A (en) | 1983-02-10 |
SE8300623D0 (sv) | 1983-02-07 |
DE3133443A1 (de) | 1983-03-10 |
FR2511357A1 (fr) | 1983-02-18 |
BE890192A (fr) | 1982-03-02 |
NL8103784A (nl) | 1983-03-01 |
US4322391A (en) | 1982-03-30 |
SE450830B (sv) | 1987-08-03 |
AU551710B2 (en) | 1986-05-08 |
FR2511357B1 (fr) | 1986-09-05 |
US4302446A (en) | 1981-11-24 |
CH647216A5 (de) | 1985-01-15 |
JPS5832029A (ja) | 1983-02-24 |
CA1152289A (en) | 1983-08-23 |
ATA374981A (de) | 1983-12-15 |
JPH0313174B2 (sv) | 1991-02-21 |
GB2103591B (en) | 1985-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8300623L (sv) | Farmaceutisk komposition innehallande stabil mikrokristallin cis-platina(ii)-diammindiklorid (cisplatin) | |
SE7903817L (sv) | Moranolinderivat | |
NO821832L (no) | Fremgangsmaate for fremstilling av allergenholdige kapsler | |
ES8800946A1 (es) | Un procedimiento para preparar derivados de guanina | |
NO173998C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
DE59410151D1 (de) | Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe | |
FI940696A0 (sv) | Nya pyrazinderivat, deras framställning och användning | |
NO870560D0 (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat | |
ES478967A1 (es) | Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7. | |
BG60101B2 (bg) | Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол | |
ES8105997A1 (es) | Un procedimiento para la preparacion de fenil-quinolicidinas | |
NO810480L (no) | Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater | |
ATE2746T1 (de) | Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
ATE4808T1 (de) | Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
SE8106498L (sv) | Kvaternera salter av n,n3-di(beta-brompropionyl)-n1,n2-dispirotripiperazinium, forfarande for framstellning av desamma och lekemedelspreparat innehallande desamma | |
BG28243A3 (en) | Incecticide means | |
FR2276033A1 (fr) | Derives actifs d'acetoxime, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions | |
ES512748A0 (es) | "procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina". | |
JPS5251362A (en) | Preparation of optically active pyrrolidine derivatives | |
ATE1011T1 (de) | 5-fluoruracil-derivate, deren herstellung und ihre pharmazeutischen zusammensetzungen. | |
SE8303012D0 (sv) | Farmaceutisk komposition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 8300623-9 Effective date: 19940310 Format of ref document f/p: F |